Literature DB >> 1289083

Hepatocyte heterogeneity in the metabolism of amino acids and ammonia.

D Häussinger1, W H Lamers, A F Moorman.   

Abstract

With respect to hepatocyte heterogeneity in ammonia and amino acid metabolism, two different patterns of sublobular gene expression are distinguished: 'gradient-type' and 'strict- or compartment-type' zonation. An example for strict-type zonation is the reciprocal distribution of carbamoylphosphate synthase and glutamine synthase in the liver lobule. The mechanisms underlying the different sublobular gene expressions are not yet settled but may involve the development of hepatic architecture, innervation, blood-borne hormonal and metabolic factors. The periportal zone is characterized by a high capacity for uptake and catabolism of amino acids (except glutamate and aspartate) as well as for urea synthesis and gluconeogenesis. On the other hand, glutamine synthesis, ornithine transamination and the uptake of vascular glutamate, aspartate, malate and alpha-ketoglutarate are restricted to a small perivenous hepatocyte population. Accordingly, in the intact liver lobule the major pathways for ammonia detoxication, urea and glutamine synthesis, are anatomically switched behind each other and represent in functional terms the sequence of the periportal low affinity system (urea synthesis) and a previous high affinity system (glutamine synthesis) for ammonia detoxication. Perivenous glutamine synthase-containing hepatocytes ('scavenger cells') act as a high affinity scavenger for the ammonia, which escapes the more upstream urea-synthesizing compartment. Periportal glutaminase acts as a pH- and hormone-modulated ammonia-amplifying system in the mitochondria of periportal hepatocytes. The activity of this amplifying system is one crucial determinant for flux through the urea cycle in view of the high Km (ammonia) of carbamoylphosphate synthase, the rate-controlling enzyme of the urea cycle. The structural and functional organization of glutamine and ammonia-metabolizing pathways in the liver lobule provides one basis for the understanding of a hepatic role in systemic acid base homeostasis. Urea synthesis is a major pathway for irreversible removal of metabolically generated bicarbonate. The lobular organization enables the adjustment of the urea cycle flux and accordingly the rate of irreversible hepatic bicarbonate elimination to the needs of the systemic acid base situation, without the threat of hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289083     DOI: 10.1159/000468779

Source DB:  PubMed          Journal:  Enzyme        ISSN: 0013-9432


  52 in total

1.  Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.

Authors:  Natalia Qvartskhava; Philipp A Lang; Boris Görg; Vitaly I Pozdeev; Marina Pascual Ortiz; Karl S Lang; Hans J Bidmon; Elisabeth Lang; Christina B Leibrock; Diran Herebian; Johannes G Bode; Florian Lang; Dieter Häussinger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 2.  Molecular mechanisms of renal ammonia transport.

Authors:  I David Weiner; L Lee Hamm
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

3.  Plasma glutamine and ammonia concentrations in ornithine carbamoyltransferase deficiency and citrullinaemia.

Authors:  C J Wilson; P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

Review 4.  Ammonia Transporters and Their Role in Acid-Base Balance.

Authors:  I David Weiner; Jill W Verlander
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

5.  Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation.

Authors:  Allison P Dane; Sharon C Cunningham; Nicole S Graf; Ian E Alexander
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

6.  Amino Acid Profiles in Patients with Urea Cycle Disorders at Admission to Hospital due to Metabolic Decompensation.

Authors:  S Rodney; A Boneh
Journal:  JIMD Rep       Date:  2012-10-30

7.  De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells.

Authors:  J G Bode; T Peters-Regehr; A M Gressner; D Häussinger
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

Review 8.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies.

Authors:  F Diaz; S Garcia; D Hernandez; A Regev; A Rebelo; J Oca-Cossio; C T Moraes
Journal:  Gut       Date:  2007-10-19       Impact factor: 23.059

10.  Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes.

Authors:  Tanja Deurholt; Niek P van Til; Aniska A Chhatta; Lysbeth ten Bloemendaal; Ruth Schwartlander; Catherine Payne; John N Plevris; Igor M Sauer; Robert Afm Chamuleau; Ronald Pj Oude Elferink; Jurgen Seppen; Ruurdtje Hoekstra
Journal:  BMC Biotechnol       Date:  2009-10-21       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.